Get the Stockscreener App
0.9903
7.93%
0.0728
After Hours:
.96
-0.0303
-3.06%
Lineage Cell Therapeutics Inc Stock (LCTX) Forecast
The Lineage Cell Therapeutics Inc (LCTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.858, representing a -13.36% decrease from the current price of $0.9903. The highest analyst price target is $1.1735, and the lowest is $0.5424.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LCTX Price Target
Average 0.6508
(-34.28% Downside)
Is Lineage Cell Therapeutics Inc (LCTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.25 | Neutral |
| STOCH(9,6) | 50.31 | Neutral |
| STOCHRSI(14) | 83.26 | Sell |
| MACD(12,26) | -0.0258 | Buy |
| ADX(14) | 13.12 | Neutral |
| William %R | -33.62 | Neutral |
| CCI(14) | 26.19 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9537
Buy
|
0.9579
Buy
|
| MA20 |
0.9665
Buy
|
0.9743
Buy
|
| MA50 |
1.0376
Sell
|
1.0339
Sell
|
| MA100 |
1.126
Sell
|
1.131
Sell
|
| MA200 |
1.3653
Sell
|
1.2317
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, LCTX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on LCTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 50.25 indicates that LCTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 50.31 indicates that LCTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 83.26 indicates that LCTX is oversold. This suggests that LCTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.12 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 26.19 indicates that LCTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LCTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lineage Cell Therapeutics Inc financial reports and earnings history, Lineage Cell Therapeutics Inc (LCTX) stock could reach $0.0226 by 2030, $2.0009 by 2040 and $5.4293 by 2050. See the projected annual prices until 2050 of the Lineage Cell Therapeutics Inc stock below:
- Lineage Cell Therapeutics Inc (LCTX) is expected to reach an average price of $0.9861 in 2035, with a high prediction of $1.033 and a low estimate of $1.06. This indicates an $-0.43% rise from the last recorded price of $0.9903.
- Lineage Cell Therapeutics Inc (LCTX) stock is projected to chart a bullish course in 2040, with an average price target of $1.984, representing an $100.34% surge from its current level. The forecast ranges from a conservative $2.054 to a sky-high $2.0009.
- Our analysts predict Lineage Cell Therapeutics Inc (LCTX) to jump 270.10% by 2045, soaring from $3.549 to an average price of $3.6651, potentially reaching $3.5051. While $3.549 is the low estimate, the potential upside is significant.
- Lineage Cell Therapeutics Inc (LCTX) stock is expected to climb by 2050, reaching an average of $5.3795, a $443.22% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.4293 and $5.4995, respectively, highlighting the market's uncertainty.
Lineage Cell Therapeutics Inc Stock (LCTX) Year by Year Forecast
Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2026
The predicted value for Lineage Cell Therapeutics Inc (LCTX) in 2026 is set at an average of $1.1847. Estimates vary from a peak of $1.985 to a trough of $0.3844, indicating an +19.63% surge from the present price of $0.9903.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.8354 | $0.5424 | $1.1735 | -15.64% |
| December, 2026 | $1.2674 | $0.3844 | $1.2774 | +27.98% |
Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lineage Cell Therapeutics Inc (LCTX) is $0.6503, with a high forecast of $1.3004 and a low forecast of $0.000183. This indicates an -34.34% decrease from the last price of $0.9903.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1693 | $0.1693 | $1.3004 | -82.90% |
| February, 2027 | $0.1113 | $0.00733 | $0.2823 | -88.76% |
| March, 2027 | $0.0338 | $0.00974 | $0.1843 | -96.59% |
| April, 2027 | $0.2282 | $0.0478 | $0.2952 | -76.96% |
| May, 2027 | $0.1969 | $0.00119 | $0.2562 | -80.12% |
| June, 2027 | $0.0849 | $0.0849 | $0.0559 | -91.43% |
| July, 2027 | $0.0471 | $0.00893 | $0.2211 | -95.25% |
| August, 2027 | $0.282 | $0.03 | $0.4459 | -71.52% |
| September, 2027 | $0.154 | $0.124 | $0.488 | -84.45% |
| October, 2027 | $0.0159 | $0.00409 | $0.2269 | -98.39% |
| November, 2027 | $0.1991 | $0.0511 | $0.0851 | -79.89% |
| December, 2027 | $0.0528 | $0.000183 | $0.1628 | -94.67% |
Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2028
In 2028, Lineage Cell Therapeutics Inc (LCTX) is projected to reach an average price of $0.2178, with a high projection of $0.4194 and a low estimate of $0.0163. This indicates an -78.00% fall from the last price of $0.9903.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2577 | $0.0188 | $0.2618 | -73.97% |
| February, 2028 | $0.0603 | $0.0163 | $0.2607 | -93.91% |
| March, 2028 | $0.1817 | $0.0673 | $0.3587 | -81.66% |
| April, 2028 | $0.1736 | $0.0936 | $0.2846 | -82.47% |
| May, 2028 | $0.2186 | $0.0166 | $0.2856 | -77.93% |
| June, 2028 | $0.2305 | $0.1515 | $0.3675 | -76.72% |
| July, 2028 | $0.1855 | $0.1165 | $0.3425 | -81.27% |
| August, 2028 | $0.2274 | $0.0814 | $0.2474 | -77.04% |
| September, 2028 | $0.2294 | $0.1694 | $0.4194 | -76.84% |
| October, 2028 | $0.2843 | $0.2024 | $0.4143 | -71.29% |
| November, 2028 | $0.2063 | $0.2033 | $0.3773 | -79.17% |
| December, 2028 | $0.0882 | $0.0832 | $0.2972 | -91.09% |
Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2029
The 2029 price forecast for Lineage Cell Therapeutics Inc Stock (LCTX) is $0.3013 on average, with a high prediction of $0.6009 and a low estimate of $0.00179. This represents an -69.57% decrease from the previous price of $0.9903.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0432 | $0.0042 | $0.2772 | -95.64% |
| February, 2029 | $0.1249 | $0.00616 | $0.1191 | -87.39% |
| March, 2029 | $0.0229 | $0.0795 | $0.0589 | -97.69% |
| April, 2029 | $0.052 | $0.00604 | $0.262 | -94.75% |
| May, 2029 | $0.056 | $0.015 | $0.115 | -94.34% |
| June, 2029 | $0.0159 | $0.00206 | $0.15 | -98.39% |
| July, 2029 | $0.4709 | $0.0289 | $0.6009 | -52.45% |
| August, 2029 | $0.1428 | $0.1028 | $0.5539 | -85.58% |
| September, 2029 | $0.0948 | $0.0349 | $0.4117 | -90.43% |
| October, 2029 | $0.0672 | $0.00222 | $0.1178 | -93.22% |
| November, 2029 | $0.0417 | $0.00179 | $0.1217 | -95.79% |
| December, 2029 | $0.083 | $0.0369 | $0.1947 | -91.62% |
Lineage Cell Therapeutics Inc Stock (LCTX) Price Forecast for 2030
Lineage Cell Therapeutics Inc Stock (LCTX) is expected to reach an average price of $0.1847 in 2030, with a high forecast of $0.3676 and a low forecast of $0.00182. This signifies an -81.35% decrease from the last price of $0.9903.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0224 | $0.0894 | $0.0226 | -97.74% |
| February, 2030 | $0.00946 | $0.0388 | $0.0446 | -99.04% |
| March, 2030 | $0.0762 | $0.0695 | $0.0295 | -92.30% |
| April, 2030 | $0.3207 | $0.0895 | $0.2726 | -67.62% |
| May, 2030 | $0.3836 | $0.3696 | $0.3154 | -61.26% |
| June, 2030 | $0.2812 | $0.3255 | $0.3676 | -71.60% |
| July, 2030 | $0.1777 | $0.1786 | $0.1827 | -82.06% |
| August, 2030 | $0.3353 | $0.2993 | $0.30 | -66.15% |
| September, 2030 | $0.4168 | $0.3663 | $0.3608 | -57.91% |
| October, 2030 | $0.3749 | $0.3478 | $0.3249 | -62.15% |
| November, 2030 | $0.1277 | $0.1529 | $0.3217 | -87.11% |
| December, 2030 | $0.222 | $0.00182 | $0.3561 | -77.58% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):